Skip to content

Optimization of the Acquisition Sequence to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam

Optimization of the Acquisition Sequence to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04645628
Acronym
AIMANT
Enrollment
720
Registered
2020-11-27
Start date
2020-12-04
Completion date
2028-12-01
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects, Patient Performing an MRI Examination

Brief summary

The purpose of this study is to evaluate the optimization of MRI acquisition sequences.

Interventions

All subjects (healthy subjects and patients) will have an MRI examination with optimized sequences

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for all subjects : * to be over 18 year-old, * to be able to understand the instructions given, * to be enrolled in a social security plan, * to have underwent a pre-inclusion medical examination, * to give a written consent. Inclusion Criteria especially for Patients : * to perform a MRI examination of the head, neck, spine, thorax, abdomen, pelvis, retroperitoneum, lower limbs, upper limbs or whole body during clinical follow-up care.

Exclusion criteria

for all subjects : * any contraindication to MR examination (active medical device, ferromagnetic foreign body, pregnancy, morbid obesity, claustrophobia, … ), * subject under a measure of legal protection.

Design outcomes

Primary

MeasureTime frameDescription
Image quality based on standard imaging quality criteria.6 months after the last inclusionThe image quality will be appreciated visually at least by a radiologist or a researcher.

Secondary

MeasureTime frameDescription
Comparison of the Signal to Noise Ratio obtained by the optimized MRI sequence and the reference situation (standard sequence).6 months after the last inclusionSignal to Noise Ratio will be measured in arbitrary units.
Comparison of the Contrast to Noise Ratio obtained by the optimized MRI sequence and the reference situation (standard sequence).6 months after the last inclusionContrast to Noise Ratio will be measured in arbitrary units.
Comparison of the acquisition time obtained with the optimized MRI sequence and the reference situation (standard sequence).6 months after the last inclusionTime acquisition will be evaluated in minutes.
Comparison of blurring and artefacts obtained by the optimized MRI sequence and the reference situation (standard sequence).6 months after the last inclusionAbsence of blurring and artefacts will be assessed by at least one radiologist according to an ordinal scale.
Comparison of the spatial resolution obtained by the optimized MRI sequence and the reference situation (standard sequence).6 months after the last inclusionSpatial resolution will be measured in mm².
Qualification of the MRI acquisition for a clinical study.6 months after the inclusionValidation of MRI acquisition by a centralized review center.
Evaluation of intra-subject reproducibility on the same MRI and on two MRIs.6 months after the last inclusionMeasurement of intra-subject reproducibility on the same MRI and on two MRIs by the intra-class correlation coefficient for quantitative measurement or by the kappa coefficient for a qualitative measurement.

Countries

France

Contacts

CONTACTValérie LAURENT, MD, PhD
v.laurent@chru-nancy.fr+33383154181
CONTACTGabriela HOSSU, PhD
g.hossu@chru-nancy.fr+33383155096

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026